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Protein phosphatase activities in extracts of the yeast Saccharomyces revisiae showed remarkable similarities to the 
mammalian type 1, type 2A and type 2C enzymes. Similarities included their substrate specificities, including selectivity 
for the ~t- and fl-subunits of muscle phosphorylase kinase, sensitivity to okadaic acid and to mammalian i hibitor 1 and 
inhibitor 2, and requirement for divalent cations. The results uggest that the function and regulation of these enzymes 
has been highly conserved uring evolution and indicate that the improved procedure for identifying and quantitating 
protein phosphatases [(1989) FEBS Lett. 250, 000-000] may be applicable to all eukaryotic ells. 
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1. INTRODUCTION 
Serine/threonine-specific protein phosphatases 
in the cytoplasmic ompartment of mammalian 
cells have been divided into two groups (type 1 and 
type 2). Type 1 enzymes are inhibited by 
nanomolar concentrations of two thermostable 
proteins, inhibitor-1 and inhibitor-2 and dephos- 
phorylate the/?-subunit of phosphorylase kinase 
specifically, while the type 2 enzymes are unaf- 
fected by the inhibitors and preferentially 
dephosphorylate the ce-subunit of phosphorylase 
kinase. The type 2 phosphatases comprise three 
distinct groups of enzymes, termed 2A (active in 
the absence of divalent cations), 2B (Ca2+-de - 
pendent) and 2C (Mg2+-dependent) reviewed in [1]. 
In the preceding paper [2] a new procedure was in- 
troduced for distinguishing type 1, type 2A and 
type 2C protein phosphatases which greatly im- 
proves their identification and quantitation in 
tissue xtracts. The method employs inhibitors 1or 
2 in conjunction with the tumour promoter 
okadaic acid. The latter is an inhibitor of type 1 
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and type 2A (but not type 2C) protein phosphatases 
[3,4], although it inhibits type 2A phosphatases 
1000-fold more potently than the type 1 enzymes in 
vitro [2]. This makes it possible to inhibit type 2A 
phosphatases specifically, or both type 1 and type 
2A together, by including okadaic acid in the 
assays at 1 nM or 1/~M, respectively. 
In this paper, we use the new methodology to
demonstrate r markable similarities between the 
protein phosphatases present in extracts of the 
yeast Saccharomyces revisiae and those in mam- 
malian cells. 
2. EXPERIMENTAL 
2.1. Yeast Strains 
The multiply proteinase-deficient strains of Saccharomyces 
cerevisiae ABYSI and ABYS66 (a pral prbl prcl cpsl ade-) 
used in this work [5] were kindly provided by Dr Dieter Wolf. 
S.cerevisiae strain XH73-3B (ce his3 leu2 glcl) was obtained 
from Dr Rotraud Wieser. 
2.2. Preparation of yeast cell extracts 
Overnight cultures of yeast were subcultured into 50 ml of 
fresh YPD medium (10 gl/1 yeast extract, 20 g/1 peptone, 2070 
glucose) at 0.1 A6oo/ml and shaken at 28 °C until a density of 0.5 
A~oo/ml was reached. The culture was pelleted and the cells 
washed by resuspension at 100 mg wet wt/ml in 100 mM Tris- 
HCI (pH 8.5), 10 mM EDTA and 10 mM 2-mercaptoethanol. 
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The cells were collected by centrifugation for 2 min at 13 000 
× g and resuspended in 0.1 ml of lysis buffer per 100 mg wet wt. 
Lysis buffer contained 100 mM Tris-HC1 (pH 7.0), 2 mM 
EDTA, 0.5°70 B-mercaptoethanol, 4 mM phenylmethylsul- 
phonyl fluoride, 2/~g/ml pepstatin, 2/~g/ml antipain, 2/zg/ml 
leupeptin and 2 /~g/ml chymostatin. 0 45 mm diameter acid- 
washed glass beads were added at a ratio 7 g/ml lysis buffer. 
After cooling on ice, the tubes were mixed by vortexing for 2 
min. Following a second cycle of cooling and vortexing, the 
mixture was examined microscopically to confirm cell lysis. The 
lysate was recovered from the glass beads by brief, low-speed 
centrifugation through a hole pierced in the apex of the 
microcentrifuge tube, and clarified by centrifugation for 2 min 
at 13 000 × g. The extracts, whose protein concentrations 
determined by the Bradford procedure [6] ranged from 17 to 20 
mg/ml, were either used immediately orfrozen rapidly in liquid 
nitrogen and stored at -70°C, prior to assay. The same phos- 
phatase activities were measured whether the extracts were used 
fresh or frozen. 
2.3. Other procedures 
Type 2B protein phosphatase activity was assayed using 32p. 
labelled inhibitor 1 [7], provided by Miss Lindsay MacDougall 
in this laboratory. Trifluoperazine was obtained from Smith, 
Kline and French, USA. Sources of other materials, preparation 
of rat liver extracts, 32p-substrates and phosphatase assays are 
given in the preceding paper [2]. 
3. RESULTS 
Type 1 and type 2A protein phosphatases are 
the only enzymes in mammalian tissues with 
significant activity towards glycogen phosphory- 
lase in the absence of divalent cations [8], and in- 
itial experiments were therefore carried out with 
this substrate. These experiments revealed that 
about half the phosphorylase phosphatase activity 
in ABYS66 extracts could be inhibited by 0.1/zM 
inhibitor 1, and half by 1 nM okadaic acid (fig. 1). 
In strain ABYS1 about a third of the 
phosphorylase phosphatase activity was inhibited 
by 0.1 /~M inhibitor 1 and two thirds by 1 nM 
okadaic acid. Furthermore, the effects of these in- 
hibitors were additive, in that activity remaining in 
the presence of inhibitor 1 could be completely sup- 
pressed by 1 nM okadaic acid, while activity re- 
maining in the presence of 1 nM okadaic acid could 
be blocked by addition of inhibitor 1 (fig. 1). In- 
hibitor 1 could be replaced by inhibitor 2 with iden- 
tical results (not shown). These results were very 
similar to those obtained with extracts of several 
mammalian tissues [2], suggesting that 
phosphorylase phosphatase activity in yeast ex- 
tracts can be attributed to two enzymes, a type 1 
phosphatase that is sensitive to inhibitor 1 and a 
type 2 phosphatase which is inactivated by 1 nM 
okadaic acid. 
Phosphorylase phosphatase and casein phos- 
phatase activity insensitive to the inhibitor proteins 
was inhibited by okadaic acid with an ICso of = 0.1 
nM (fig.2), similar to that which inhibits mam- 
malian type 2A phosphatases under the same con- 
ditions [2]. By contrast, phosphorylase 
phosphatase activity not inhibited by 1 nM okadaic 
acid (but sensitive to inhibitor 1) was only inac- 
tivated at higher concentrations of okadaic acid. 
The ICso (30 nM) was slightly greater than that 
which inhibits mammalian type 1 phosphatases [2]. 
The dephosphorylation of muscle phosphorylase 
kinase by extracts of strain ABYS66 (fig.3) and 
ABYS1 (not shown) was inhibited #95°7o by in- 
hibitor 1 or inhibitor 2 from mammalian skeletal 
muscle, with ICso values of 2 nM and 5 nM, respec- 
tively (fig.3). These ICso values were only two-fold 
higher than those observed for inhibition of type 1 
phosphatases in rabbit skeletal muscle extracts 
under the same conditions (inhibitor l, 1 nM; in- 
hibitor 2, 2 nM, not shown). Consistent with the 
results in fig.3, yeast extracts dephosphorylated he
~?-subunit of phosphorylase kinase selectively 
(fig.4A) and dephosphorylation f this substrate 
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Fig. 1. Effect of okadaic acid and inhibitor 1 on phosphorylase 
phosphatase activity in extracts of S.cerevisiae (strain ABYS66). 
Assays were performed in the absence of divalent cations at a 
75-fold dilution of the extracts in the presence of 1 nM okadaic 
acid (OA), after 10 min preincubation with 0.1/zM inhibitor 1 
0-1), or okadaic acid (1 nM) plus inhibitor 1 (OA + I-l), or in 
the absence of either inhibitor (C, control). Similar results were 
obtained in experiments carried out on three extracts prepared 
from strain ABYS66 and three from ABYS1. 
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Fig.2. Effect of okadaic acid on protein phosphatase activities 
in extracts of S.cerevisiae (strain ABYS1). Assays were carried 
out without divalent cations at a 75-fold ilution of the extracts. 
Type 2A activity (PP2A) was measured after preincubation for
10 min with 0.1/~M inhibitor 1, using glycogen phosphorylase 
(©) and casein (V) as substrates. Type 1 activity (PP1) was 
determined in the absence of inhibitor 1 using phosphorylase 
(e) or phosphorylase kinase (V) as substrate; with 
phosphorylase only, the graph was plotted after subtracting 
activity measured at1 nM okadaic acid to correct for type 2A 
phosphatase. 
was inhibited by okadaic acid similarly to the in- 
hibitor 1-sensitive phosphorylase phosphatase ac- 
tivity (fig.2). 
The Mg2+-dependent type 2C protein phos- 
phatase is unaffected by okadaic acid [3], allowing 
its identification and quantitation in mammalian 
tissue extracts by inclusion of this substance in the 
assays [2]. In the presence of 5/~M okadaic acid, 
activity in yeast extracts towards casein or phos- 
phorylase kinase was completely dependent on 
Mg 2÷, the Ao.5 values of 1.0 and 1.6 mM, respec- 
tively (fig.5), being similar to those of type 2C 
phosphatases in mammalian extracts [2]. Like 
mammalian type 2C phosphatases, the Mg2+-de- 
pendent activity in yeast extracts was specific for 
the oe-subunit of phosphorylase kinase (fig.4B) and 
unaffected by inhibitors 1 and 2 at 0.1/zM. 
The activity ratios casein phosphatase:phos- 
phorylase kinase phosphatase:phosphorylase 
phosphatase in yeast and liver extracts were similar 
for the type 2A and type 2C enzymes (table 1). The 
specific activity of type 2C phosphatase was similar 
in yeast and liver extracts, and as in mammalian 
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Fig.3. Effect of  inhibitor ] (open circles) and inhibitor 2 (closed 
circles) on phosphorylase kinase phosphatase activity in yeast 
(strain ABYS66) extracts. Experiments were carried out in the 
absence of divalent cations at a 75-fold ilution of the extracts. 
tissues this enzyme had low activity towards glyco- 
gen phosphorylase (table 1). Type 2A specific ac- 
tivity was 3-4 fold lower in yeast than in rat liver 
extracts (table 1), but only slightly lower than in 
rabbit skeletal muscle extracts (not shown). As in 
mammalian tissue extracts, the yeast ype 1 enzyme 
had extremely low activity towards casein, type 2A 
phosphatases accounting for virtually all casein 
phosphatase activity in the absence of divalent 
cations (table 1). By contrast, type 1 phosphatases 
accounted for almost all the activity towards phos- 
phorylase kinase (table 1). 
The striking difference between yeast and mam- 
malian extracts was the 10-fold lower phosphory- 
lase phosphatase:phosphorylase kinase phospha- 
tase activity ratio of the yeast type 1 phosphatase. 
In mammalian tissues, brief tryptic digestion 
releases the type 1 catalytic subunits from other 
proteins to which they are complexed in vivo [9]. 
Following incubation of yeast extracts at ambient 
temperature with 0.25 mg/ml trypsin and subse- 
quent addition of excess trypsin inhibitor to stop 
the reaction [9], type 1 phosphorylase phosphatase 
activity increased 7-8 fold after 2 min without any 
change in type 2A activity. More prolonged iges- 
tion decreased both type 1 and type 2A activity. 
Since activity towards phosphorylase kinase in- 
creased by only 50% after 2 min incubation with 
trypsin, the results suggest hat the phosphorylase 
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Fig.4. Dephosphorylation f the ~- and fl-subunits of phos- 
phorylase kinase by extracts of S.cerevisiae strain ABYS1. (A) 
Experiments were performed in the absence of divalent cations 
and okadaic acid and presence of 0.1 mM EGTA at a 25-fold 
dilution of the extracts. (B) Experiments were carried out in the 
presence of 20 mM magnesium acetate and 5/zM okadaic acid 
at 15-fold dilution of the extracts. The phosphorylase kinase 
substrate contained 0.85 mol phosphate/,6'-subunit and 0.81 mol 
phosphate/oz-subunit. Release of phosphate from the oe (©) and 
# (o) subunits was quantitated as in [14]. 
phosphatase activity of  the yeast type 1 
phosphatase is suppressed through its interaction 
with another protein(s). Tryptic digestion of  rat 
liver extracts maximally increased type 1 
phosphorylase phosphatase activity by only 70°70, 
when assayed at high di lution as described in 
table 1. 
The Ca2+-dependent, calmodul in-st imulated 
(type 2B) protein phosphatase is assayed in tissue 
extracts by the dephosphorylat ion of inhibitor 1 
[7], but CaZ+/calmodul in-dependent type 2B ac- 
tivity could not be detected in yeast extracts, in the 
presence of  10 nM or 1/~M okadaic acid (these con- 
centrations do not inhibit the mammal ian  type 2B 
enzyme significantly [3]) and in the presence or 
absence of  5 mM Mg 2+. Since mammal ian  type 2B 
phosphatases can be converted to forms that are 
only active in the presence o f  Mn 2+ [7], further ex- 
periments were performed in which this cation 
replaced Ca 2÷ in the assays. Mn2+-dependent in- 
hibitor 1 phosphatase activity was detected in the 
yeast extracts that was stimulated 50070 by 0.2/zM 
sheep brain calmodul in,  and inhibited 50°7o by 0.1 
mM tr i f luoperazine (in the presence or absence of  
Table 1 
Specific activities of protein phosphatases in extracts of S. cerevisiae (strain ABYS1) and rat liver 
Phosphorylase Phosphorylase Casein phosphatase 
phosphatase kinase phosphatase 
(mU/mg) (mU/mg) (mU/mg) 
Yeast extract 
Type 1 phosphatase 0.073 0.16 <0.01 
Type 2A phosphatase 0.12 < 0.014 0.26 
Type 2C phosphatase 0.018 0.079 0.23 
Rat liver extract 
Type 1 phosphatase 0.59 0.11 < 0.03 
Type 2A phosphatase 0.54 0.060 0.83 
Type 2C phosphatase 0.008 0.060 0.26 
Extracts were obtained by centrifugation ofhomogenates for 2 min at 13 000 x g (yeast) and 10 rain at 16 000 x g (liver) and assayed 
at 75-fold (yeast), 100-fold (liver type 2C) or 600-fold (liver type 1 and type 2A) dilution of the extracts using 10/~M phosphorylase, 
6/~M casein and 1/~M phosphorylase kinase. The discarded 13 000 x g pellet contained ~-20°70 of the type 1, type 2A and type 2C 
activity present in the yeast homogenates. The discarded 16 000 x g pellet contained 75070 of the type 1 activity, but very little of the 
type 2A and type 2C activity in the liver homogenates. Similar esults were obtained with several extracts of yeast strain ABYS1. Strain 
ABYS66 had similar type 1 and type 2C activity, but only about half the type 2A activity of ABYSI. A further strain, not deficient 
in proteinase activities (XH73-3B) had similar type 1 and type 2A activity to ABYSI. Type 1 phosphatase was measured as the activity 
sensitive to 0.1/~M inhibitor 1 and as the activity not inactivated by 1 nM okadaic acid, and these two values were averaged. Type 2A 
phosphatase was the average of the inhibitor 1-insensitive activity and the okadaic acid (1 nM) sensitive activity. Type 1 and type 2A 
activity measured by the two procedures agreed to within ± 10070. Type 2C phosphatase was that measured inthe presence of 20 mM 
magnesium acetate and 5/zM okadaic acid. Type 2A activity in yeast extracts towards phosphorylase kinase and type 1 activity towards 
casein in yeast and liver extracts was such a small proportion of the total activity that it could not be measured accurately (discussed 
in [2]) 
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Fig.5. Effect of Mg2+ on protein phosphatase activity in yeast 
extracts in the presence of 5rM okadaic acid. Experiments were 
performed at a 75-fold dilution of the extracts using casein 
(C--O) and phosphorylase kinase (O---O) as substrates. 
calmodulin). The trifluoperazine-sensitive activity 
(0.02 mU/mg) was 30-fold lower than in rabbit 
muscle or brain extracts and s-fold lower than in 
liver [7,8]. The trifluoperazine insensitive activity is 
likely to be catalyzed by type 2C phosphatases. 
4. DISCUSSION 
The type 1, type 2A and type 2C protein phos- 
phatases in yeast are remarkably similar to the 
mammalian enzymes. The yeast type 1 activity 
dephosphorylated the P-subunit of muscle phos- 
phorylase kinase specifically (fig.4), and was in- 
hibited by essentially the same concentrations of 
inhibitor 1, inhibitor 2 and okadaic acid as the 
mammalian type 1 enzyme (figs 2,3). These obser- 
vations suggest that yeast may contain proteins 
resembling inhibitors 1 and 2 that regulate type 1 
phosphatase activity in this organism. Similarly, 
yeast type 2A phosphatase, like the mammalian en- 
zymes, was exquisitely sensitive to okadaic acid, 
unaffected by inhibitors 1 and 2, and active 
towards phosphorylase in the absence of divalent 
cations. Yeast type 2C phosphatase was dependent 
on Mg2+ (fig.S), dephosphorylated the a-subunit 
of phosphorylase kinase specifically (fig.4B), and 
was unaffected by inhibitors 1 and 2 and okadaic 
acid. The specific activities of each phosphatase 
and their relative activities towards different 
substrates were comparable to those observed in 
mammalian extracts (table l), except for the yeast 
type 1 enzyme, whose phosphorylase phosphatase 
activity appeared to be suppressed by interaction 
with another protein. These findings indicate that 
the improved procedure for identifying and quan- 
titating mammalian protein phosphatases, describ- 
ed in the preceding paper [2], may be applicable to 
all eukaryotic cells. 
Surprisingly little work on the protein phos- 
phatases present in yeast has been carried out 
previously. Wingender-Drissen and Becker [lo] 
resolved three peaks of protein phosphatase activi- 
ty by chromatography of yeast extracts on DEAE- 
cellulose, which they termed a, b and c by their 
order of elution from the anion exchanger. All 
three peaks were active towards muscle phosphory- 
lase, but only peak c had significant activity 
towards yeast phosphorylase. Phosphatases a, b 
and c were reported to be partially inhibited by in- 
hibitor 2, but insensitive to inhibitor 1. The present 
work is in disagreement with the latter conclusion. 
Peak c was dependent on Mg2+ suggesting that it 
may be a type 2C phosphatase. In this case, the 
order of elution of this enzyme differs from mam- 
malian cells, where type 2C enzymes emerge earlier 
than the active forms of type 1 and type 2 phospha- 
tases [ll]. 
Other investigators resolved three histone phos- 
phatases by chromatography of yeast extracts on 
DEAE-cellulose that presumably equate with peaks 
a, b and c [12]. They initially reported that peak c 
was missing in the ppdl mutant of Saccharomyces 
cerevisiae [12], but subsequent studies failed to 
confirm this observation and structural analysis of 
the PPDZ gene (now renamed I&41) indicates it is 
not a protein phosphatase [ 131. 
The great advantage of yeast is that chromosome 
disruption is simple and it will be possible to delete 
and mutate genes encoding particular protein phos- 
phatases. Such mutants will be valuable in 
delineating the precise physiological roles of each 
phosphatase. This will be particularly important 
for type 2C phosphatases, which are present at high 
concentrations in yeast, but whose functions in 
mammalian cells are unknown. 
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